Jenny Shum

Delman Lebel

Head Of US Corporate Affairs

Sebastien Block

Qualified Person Responsible For Information And Publicity (qp-rip)

Yvonne Armstrong

Director Of Communications, Alexion Astrazeneca Rare Disease

Alyssa Bendyk

Head Of HR Rare Disease Business Unit, US Business

Phil Milam

Senior Director, Access And Reimbursement US (rare Disease)

Matt Hay

U.s. Director Of Advocacy For Metabolics - Neurofibromatosis (nf) And Hypophosphatasia (hpp)

Natalie Morton

Head Of Hr, Global R&d - Alexion, Astrazeneca Rare Disease

Elizabeth Hackbarth

Director Patient Advocacy

Jonathan Monteleone

Executive Director, CPSS At Alexion, Astrazeneca Rare Disease